XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $450,912 | +88662.2% | 13,200 | 0.0% | 0.00% | – |
| Q2 2023 | $508 | -99.9% | 13,200 | -34.0% | 0.00% | -100.0% |
| Q1 2023 | $715,800 | -9.2% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $788,600 | +9.2% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $722,000 | -73.2% | 20,000 | -77.4% | 0.00% | -66.7% |
| Q2 2022 | $2,696,000 | -13.7% | 88,630 | -13.3% | 0.00% | +50.0% |
| Q1 2022 | $3,123,000 | +42.5% | 102,185 | +46.2% | 0.00% | 0.0% |
| Q4 2021 | $2,191,000 | – | 69,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |